{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:32:59Z","timestamp":1761514379232},"reference-count":44,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This section reviews the diagnostic criteria and pathogenesis of large granular lymphocyte (LGL) leukemia. There is a particular focus on the overlap of LGL leukemia and rheumatoid arthritis (Felty's syndrome). Current understanding of the mechanisms of neutropenia in these disorders is discussed. Finally, treatment indications and therapeutic recommendations are outlined.<\/jats:p>","DOI":"10.1182\/asheducation-2017.1.181","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T22:13:11Z","timestamp":1555452791000},"page":"181-186","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["Chronic neutropenia in LGL leukemia and rheumatoid arthritis"],"prefix":"10.1182","volume":"2017","author":[{"given":"Tal","family":"Gazitt","sequence":"first","affiliation":[{"name":"University of Washington, Seattle, WA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Thomas P.","family":"Loughran","sequence":"additional","affiliation":[{"name":"University of Virginia, Charlottesville, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"6","key":"2019111705570736800_B1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/leu.2016.68","article-title":"Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013","volume":"30","author":"Dinmohamed","year":"2016","journal-title":"Leukemia"},{"issue":"8","key":"2019111705570736800_B2","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1038\/bcj.2016.59","article-title":"A population-based study of large granular lymphocyte leukemia","volume":"6","author":"Shah","year":"2016","journal-title":"Blood Cancer J"},{"issue":"9","key":"2019111705570736800_B3","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3324\/haematol.2009.018481","article-title":"Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases","volume":"95","author":"Bareau","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"2019111705570736800_B4","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2014.298","article-title":"Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the eastern cooperative oncology group (E5998)","volume":"29","author":"Loughran","year":"2015","journal-title":"Leukemia"},{"issue":"20","key":"2019111705570736800_B5","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2019111705570736800_B6","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","article-title":"How I treat LGL leukemia","volume":"117","author":"Lamy","year":"2011","journal-title":"Blood"},{"issue":"25","key":"2019111705570736800_B7","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1182\/blood-2013-05-506386","article-title":"Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes","volume":"122","author":"Clemente","year":"2013","journal-title":"Blood"},{"key":"2019111705570736800_B8","first-page":"1082","article-title":"LGL leukemia: from pathogenesis to treatment","author":"Lamy","year":"2017"},{"issue":"5","key":"2019111705570736800_B9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/10428190801932635","article-title":"Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia","volume":"49","author":"Viny","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"2019111705570736800_B10","first-page":"1","article-title":"Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)","volume":"20","author":"Sanikommu","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"20","key":"2019111705570736800_B11","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"2019111705570736800_B12","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2019111705570736800_B13","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"issue":"20","key":"2019111705570736800_B14","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood-2016-06-724856","article-title":"High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia","volume":"128","author":"Andersson","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2019111705570736800_B15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.29697","article-title":"Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia","volume":"138","author":"Johansson","year":"2016","journal-title":"Int J Cancer"},{"key":"2019111705570736800_B16","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1038\/bcj.2013.65","article-title":"Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation","volume":"3","author":"Andersson","year":"2013","journal-title":"Blood Cancer J"},{"issue":"3","key":"2019111705570736800_B17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111705570736800_B18","first-page":"529","article-title":"Constitutive production of proinflammatory cytokines RANTES, MIP-1\u03b2 and IL-18 characterizes LGL leukemia","volume":"26","author":"Kothapalli","year":"2005","journal-title":"Int J Oncol"},{"issue":"3","key":"2019111705570736800_B19","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2007-06-093823","article-title":"Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia","volume":"111","author":"Yang","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111705570736800_B20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood-2007-11-121871","article-title":"Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes","volume":"112","author":"Shah","year":"2008","journal-title":"Blood"},{"issue":"42","key":"2019111705570736800_B21","doi-asserted-by":"crossref","first-page":"16308","DOI":"10.1073\/pnas.0806447105","article-title":"Network model of survival signaling in large granular lymphocyte leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111705570736800_B22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2009-06-223719","article-title":"Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway","volume":"115","author":"Yang","year":"2010","journal-title":"Blood"},{"key":"2019111705570736800_B23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1874312901408010129","article-title":"Felty\u2019s Syndrome, Insights and Updates","volume":"8","author":"Owlia","year":"2014","journal-title":"Open Rheumatol J"},{"issue":"4","key":"2019111705570736800_B24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOH.0b013e32834760fb","article-title":"The spectrum of large granular lymphocyte leukemia and Felty\u2019s syndrome","volume":"18","author":"Liu","year":"2011","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"2019111705570736800_B25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2006.01.003","article-title":"Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome","volume":"20","author":"Burks","year":"2006","journal-title":"Blood Rev"},{"issue":"178","key":"2019111705570736800_B26","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"2019111705570736800_B27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.33432","article-title":"Felty\u2019s syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps","volume":"64","author":"Dwivedi","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2019111705570736800_B28","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/art.39283","article-title":"Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis","volume":"67","author":"Sohn","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"209","key":"2019111705570736800_B29","doi-asserted-by":"crossref","first-page":"209ra150","DOI":"10.1126\/scitranslmed.3006869","article-title":"Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis","volume":"5","author":"Romero","year":"2013","journal-title":"Sci Transl Med"},{"key":"2019111705570736800_B30","first-page":"1","article-title":"Characterization of the hypercitrullination reaction in human neutrophils and other leukocytes","volume-title":"Mediators Inflamm","author":"Zhou","year":"2015"},{"issue":"2","key":"2019111705570736800_B31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"issue":"2","key":"2019111705570736800_B32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/emmm.201201846","article-title":"The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes","volume":"5","author":"Cloutier","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"2","key":"2019111705570736800_B33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/ard.42.2.158","article-title":"Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid","volume":"42","author":"Gale","year":"1983","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2019111705570736800_B34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.43.1.34","article-title":"Neutrophil activation by immune complexes and the role of rheumatoid factor","volume":"43","author":"Gale","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2019111705570736800_B35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jbspin.2015.01.005","article-title":"Management of neutropenia in patients with rheumatoid arthritis","volume":"82","author":"Lazaro","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"7","key":"2019111705570736800_B36","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/blood-2002-09-2898","article-title":"Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells","volume":"101","author":"Papadaki","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2019111705570736800_B37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.1995.tb05277.x","article-title":"Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia","volume":"91","author":"Maciejewski","year":"1995","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111705570736800_B38","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"issue":"4","key":"2019111705570736800_B39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archinte.1978.03630280059020","article-title":"Splenectomy for Felty\u2019s syndrome. Clinicopathological study of 27 patients","volume":"138","author":"Laszlo","year":"1978","journal-title":"Arch Intern Med"},{"issue":"8","key":"2019111705570736800_B40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.45.8.696","article-title":"Immune complexes and the pathogenesis of neutropenia in Felty\u2019s syndrome","volume":"45","author":"Breedveld","year":"1986","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2019111705570736800_B41","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.4049\/jimmunol.161.7.3666","article-title":"Modulation of human neutrophil apoptosis by immune complexes","volume":"161","author":"Gamberale","year":"1998","journal-title":"J Immunol"},{"issue":"3","key":"2019111705570736800_B42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0268-960X(96)90024-7","article-title":"Treatment of the neutropenia of Felty syndrome","volume":"10","author":"Rashba","year":"1996","journal-title":"Blood Rev"},{"issue":"5","key":"2019111705570736800_B43","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/leu.2013.359","article-title":"Cyclophosphamide as a first-line therapy in LGL leukemia","volume":"28","author":"Moignet","year":"2014","journal-title":"Leukemia"},{"key":"2019111705570736800_B44","first-page":"1078","article-title":"Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia","volume-title":"Exp Hematol","author":"Subbiah","year":"2008"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/181\/1251011\/hem00025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2017\/1\/181\/1251011\/hem00025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T20:21:33Z","timestamp":1694809293000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2017\/1\/181\/21163\/Chronic-neutropenia-in-LGL-leukemia-and-rheumatoid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2017.1.181","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}